The Tri-Institutional Therapeutics Discovery Institute (TDI) is happy to announce an open request for Therapeutic Small Molecule Proposals. Applications consist of a brief letter of intent that includes a basic description of the project, unmet medical need, and scientific rationale for generating therapeutic small molecules against the selected targets.
The deadline for submission of a letter of intent is April 24th, 2018. Please find additional information below along with a link to our application website.
This opportunity is exclusive to investigators at Memorial Sloan Kettering Cancer Center, The Rockefeller University and Weill Cornell Medicine. We encourage you take advantage of this unique opportunity!